CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Ranitidine +3 moredrug
Likely dose
Ranitidine 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00585351
NCT00585351N/ACompleted

Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting (AIRDOC)

University of Iowa·interventional·Posted Jan 3, 2008·Updated Jan 16, 2013

In Brief

A clinical study evaluating Ranitidine, Placebo, and 2 other interventions for Stroke. Completed, enrolled 100 participants across 1 site.

Detailed Summary

We are inviting patients who have been diagnosed with an ischemic or hemorrhagic stroke and are being transferred by Air Care helicopters to the University of Iowa Hospitals and Clinics (UIHC) for further care to participate in this research study to test the following: 1) To test whether it is possible to go through all the procedures necessary to start a study, including an informed consent, before the patient is transferred by helicopter to Iowa City. 2)To test a low risk medication called, Ranitidine, that might lower the chances of developing chemical pneumonitis (irritation of the lungs by stomach contents), a fairly common complication in patients that have had a stroke. Patients will be randomly assigned to receive a single dose injection of either Ranitidine (50 milligrams (mg)) or placebo (normal saline).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 3, 2008
Enrollment StartJan 1, 2007
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.5 years ago

Interventions

Ranitidinedrug

50 mg single dose injection of Ranitidine

Placebodrug

50 mg single dose injection of normal saline (placebo)

Advanced notificationother

Advanced notification of study via faxed consent to local Emergency Room (ER)

No advanced notificationother

No advanced notification of study via faxed consent to local Emergency Room (ER)